Recurrent Thymoma
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PT-112 in Subjects With Thymoma and Thymic Carcinoma (NCT05104736) | National Cancer Institute (NCI) | 2022-04-06 |
| Bintrafusp Alfa (M7824) in Subjects With Thymoma and Thymic Carcinoma (NCT04417660) | National Cancer Institute (NCI) | 2020-12-26 |
Track Recurrent Thymoma automatically
Every clearance here is in the API, with alerts when new ones post.